+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Plexiform Neurofibroma - Pipeline Insight, 2025 - Product Thumbnail Image

Plexiform Neurofibroma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Giant-Cell Arteritis - Pipeline Insight, 2025 - Product Thumbnail Image

Giant-Cell Arteritis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Viral Core Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Viral Core Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-12 Expression Stimulants - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-12 Expression Stimulants - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Type-2 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Cystic Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2025 - Product Thumbnail Image

Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Pseudomonal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Influenza Virus B Infections-Pipeline Insight, 2025 - Product Thumbnail Image

Influenza Virus B Infections-Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pneumococcal Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Hemophilia- Pipeline Insight, 2025 - Product Thumbnail Image

Hemophilia- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Type 1 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Palmar Hyperhidrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Palmar Hyperhidrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
X Linked Adrenoleukodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

X Linked Adrenoleukodystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Overactive Bladder- Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chlamydia - Pipeline Insight, 2025 - Product Thumbnail Image

Chlamydia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
AL Amyloidosis- Pipeline Insight, 2025 - Product Thumbnail Image

AL Amyloidosis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more